Document is current
Any future updates will be listed below
-
Authors
Lipp, Rainer W.
-
Funding
Funding for this research was provided by:
Medical University of Graz
- License Information
-
More Information
Article History
Received: 2 September 2022
Accepted: 14 November 2022
First Online: 19 December 2022
Conflict of interest
: R.W. Lipp received speaker fees from Nycomed Amersham, IPSEN, Novartis, Astellas and is an advisory board member of Bayer, BSM, IPSEN, Novartis, Pfizer, Merck and received travel fees from IPSEN, Novartis, Merck, Sanofi-Genzyme and Siemens.
